July 18, 2012 – Market Watch
MiniVax, Inc., a company specializing in the development of treatments for opportunistic fungal and bacterial infections, announced Dr. Bruce Beutler as the most recent addition to its Scientific Advisory Board. Dr. Beutler has over 25 years of experience in immunology research and is currently Director of the Center for the Genetics of Host Defense at the University of Texas Southwestern Medical Center.